Author: Storb U. Peters A. Klotz E. Rogerson B. Hackett Jr J.
Publisher: Academic Press
ISSN: 1044-5323
Source: Seminars in Immunology, Vol.8, Iss.3, 1996-03, pp. : 131-140
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Somatic hypermutation of Ig genes is beginning to be understood in molecular terms. Ig transgenes have served as model test genes and been shown to mutate, just as endogenous genes, with a peak of mutation over the VJ region and a sparing of the C region. The levels of somatic mutation appear to be related to the expression of the transgenes. DNA hypermethylation of modified Ig transgenes interferes with both expression and somatic hypermutation. Test substrates consisting of bacterial lacZalpha or supF tRNA inserted within kappa transgenes were shown to be rescuable as expressible bacterial plasmids, but did not seem to be targeted. A synthetic sequence consisting of alternating restriction enzyme sites, that cannot be subject to methylation, was found to be a reliable transgenic substrate for easy assay of somatic mutation.The generation of a transgenic mouse with a kappa transgene in which the transcriptional promoter has been duplicated upstream of the C region has given new clues to the mutation mechanism. In this transgene, transcripts initiate from both the C region and the V region promoters, and both regions, but not the sequences between them, are hypermutated. These results suggest that somatic hypermutation is linked to the initiation of transcription. A model is proposed in which somatic mutation is dependent on transcription coupled DNA repair.
Related content
By Tumas-Brundage K. Vora K.A. Giusti A.M. Manser T.
Seminars in Immunology, Vol. 8, Iss. 3, 1996-03 ,pp. :
The targeting of somatic hypermutation
By Jolly C.J. Wagner S.D. Rada C. Klix N. Milstein C. Neuberger M.S.
Seminars in Immunology, Vol. 8, Iss. 3, 1996-03 ,pp. :
Introduction: What mechanism(s) drive hypermutation?
By Reynaud C.A. Quint L. Bertocci B. Weill J.C.
Seminars in Immunology, Vol. 8, Iss. 3, 1996-03 ,pp. :
By Huang Xiaojun Orucevic Amila Li Mengfeng Gorelik Elieser
Clinical and Experimental Metastasis, Vol. 18, Iss. 4, 2000-06 ,pp. :